WMT

122.16

-0.77%↓

COST

979.81

+0.57%↑

142.31

-1.03%↓

74.72

-0.72%↓

162.52

-1.79%↓

WMT

122.16

-0.77%↓

COST

979.81

+0.57%↑

142.31

-1.03%↓

74.72

-0.72%↓

162.52

-1.79%↓

WMT

122.16

-0.77%↓

COST

979.81

+0.57%↑

142.31

-1.03%↓

74.72

-0.72%↓

162.52

-1.79%↓

WMT

122.16

-0.77%↓

COST

979.81

+0.57%↑

142.31

-1.03%↓

74.72

-0.72%↓

162.52

-1.79%↓

WMT

122.16

-0.77%↓

COST

979.81

+0.57%↑

142.31

-1.03%↓

74.72

-0.72%↓

162.52

-1.79%↓

Home・Akcijų sąrašas・USANA Health Sciences Inc

USANA Health Sciences Inc

Uždarymo kaina

17.26 1.05

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

16.73

Max

17.26

Pagrindiniai rodikliai
By Trading Economics
Pajamos	5.1M -1.6M
Pardavimai	13M 226M
P/E Sektoriaus vid.	29.966 27.787
Pelnas, tenkantis vienai akcijai	-0.15
Pelno marža	-0.705
Darbuotojai	1,570
EBITDA	16M 28M

Dividendai
By Dow Jones
Kitas uždarbis	2026-04-21

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-61M 321M
Ankstesnė atidarymo kaina	16.21
Ankstesnė uždarymo kaina	17.26

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

28.405 / 29.84 Palaikymas ir pasipriešinimas

USANA Health Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-26 23:43; UTC

Rinkos pokalbiai

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

2026-03-26 23:36; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

2026-03-26 23:35; UTC

Įsigijimai, susijungimai, perėmimai

Pernod Ricard: Confirms Discussions With Brown-Forman

2026-03-26 23:29; UTC

Uždarbis

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

2026-03-26 23:28; UTC

Uždarbis

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

2026-03-26 23:28; UTC

Uždarbis

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

2026-03-26 23:28; UTC

Uždarbis

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

2026-03-26 23:27; UTC

Uždarbis

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

2026-03-26 23:27; UTC

Uždarbis

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

2026-03-26 23:08; UTC

Rinkos pokalbiai

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

2026-03-26 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

2026-03-26 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

2026-03-26 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

2026-03-26 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

2026-03-26 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Pernod in Deal Talks With Brown-Forman -- WSJ

2026-03-26 22:41; UTC

Įsigijimai, susijungimai, perėmimai

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

2026-03-26 22:41; UTC

Įsigijimai, susijungimai, perėmimai

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

2026-03-26 22:26; UTC

Uždarbis

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

2026-03-26 22:26; UTC

Uždarbis

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

2026-03-26 22:26; UTC

Uždarbis

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

2026-03-26 22:08; UTC

Uždarbis

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

2026-03-26 22:08; UTC

Uždarbis

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

2026-03-26 22:08; UTC

Uždarbis

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

2026-03-26 22:07; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Global Energy Roundup: Market Talk

2026-03-26 22:07; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

2026-03-26 22:00; UTC

Uždarbis

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

2026-03-26 22:00; UTC

Uždarbis

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

2026-03-26 22:00; UTC

Uždarbis

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

2026-03-26 21:39; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

2026-03-26 21:38; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

Akcijų palyginimas

Kainos pokytis

USANA Health Sciences Inc Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių USANA Health Sciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

28.405 / 29.84Palaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.